Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations

Fig. 3

Cost-effectiveness plane of different preventive strategies:(A) discounted total life-time costs (in €) versus effectiveness expressed in discounted total life years (LYs) and (B) discounted total life-time costs (in €) versus discounted total quality-adjusted life years (QALYs). The respective stepwise ICER (in €/LY) and ICUR (in €/QALY) on the efficiency frontier (blue line) are shown in boxes. Reference strategy: PBM at age 30 and PBSO at age 40 (S12)

PBM: Prophylactic bilateral mastectomy; PBSO: Prophylactic bilateral salpingo-oophorectomy; y: years of age

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us